Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000553669 | SCV000632224 | benign | Idiopathic generalized epilepsy; Hyperaldosteronism, familial, type IV | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002506318 | SCV002805253 | likely benign | Epilepsy, childhood absence, susceptibility to, 6; Hyperaldosteronism, familial, type IV | 2021-09-07 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004715261 | SCV005296944 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004541669 | SCV004786584 | benign | CACNA1H-related disorder | 2019-05-08 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |